COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,445 Articles (22,835 medRxiv, 8,610 bioRxiv)

Most recent first Previous |  Page 1183: Articles 11821-11830  | Next

Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection
Tyner, H. L., Thompson, M. G., Burgess, J. L., Grant, L., Gaglani, M., Kuntz, J. L., Naleway, A. L., Thornburg, N. J., Caban-Martinez, A. J., Yoon, S. K., Herring, M. K., Beitel, S. C., Blanton, L., Nikolich-Zugich, J., Thiese, M. S., Flores Pleasants, J., Fowlkes, A. L., Lutrick, K., Dunnigan, K., Yoo, Y. M., Rose, S., Groom, H., Meece, J., Wesley, M. G., Schaefer-Solle, N., Louzado-Feliciano, P., Edwards, L. J., Olsho, L. E. W.
10.1101/2021.10.20.21265171 — Posted: 2021-10-26
COVID-19 Observations from Hospitalized Ward Patients in the Northern Emirates: A Practice Only Preached.
Qureshi, S., Kampani, D. D., Al-Qutbi, T. A. H.
10.1101/2021.10.20.21265254 — Posted: 2021-10-26
Mathematical modeling of COVID-19 in British Columbia:an age-structured model with time-dependent contact rates
Iyaniwura, S. A., Falcão, R. C., Ringa, N., Adu, P., Spencer, M., Taylor, M., Colijn, C., Coombs, D., Janjua, N. Z., Irvine, M., Otterstatter, M.
10.1101/2021.10.19.21265177 — Posted: 2021-10-26
Preclinical and clinical validation of a novel injected molded swab for molecular assay detection of SARS-CoV-2 virus
Ghezzi, C. E., Hartigan, D. R., Hardick, J., Gore, R., Adelfio, M., Diaz, A. R., McGuiness, P. D., Robinson, M. L., Buchholz, B. O., Manabe, Y. C. L.
10.1101/2021.10.19.21265200 — Posted: 2021-10-26
The Relationship Between Food Security and Dietary Patterns Status with COVID-19 in Northeastern Iran: Protocol for a Case-Control Study
Badri-Fariman, S., Pourghassem-Gargari, B., Badri-Fariman, M., Pourfridoni, M., Daneshi-Maskooni, M.
10.1101/2021.10.20.21265103 — Posted: 2021-10-26
Early COVID-related Acute Kidney Injury Recovery May Course with Hydroelectrolytic Disorders in Patients With High Risk of Insensible Fluid Loss
Braga Barbosa, G. S., de Jesus Torres de Melo, A. G., Gomes Ribeiro, R., del Pilar Via Reque Cortes, D., Sandoval Cabrera, C. P., Santos Andrade Filho, R., Tamborra Pantaroto, G., de Castro Paul Schultze, B., Paula, G. A., Rodrigues, C. E.
10.1101/2021.10.20.21265300 — Posted: 2021-10-26
Network analysis of England single parent household COVID-19 control policy impact; a proof-of-concept study
Edelman, N. L., Simon, P., Cassell, J. A., Kiss, I.
10.1101/2021.10.26.21265363 — Posted: 2021-10-26
REcovery and SURvival of patients with moderate to severe acute REspiratory distress syndrome (ARDS) due to COVID-19: a multicentre, single-arm, Phase IV Itolizumab Trial: RESURRECT
KR, R., Rathod, C., Darnule, R., Loganathan, S., Deodhar, S., A, R., Marwah, A., Chaudhari, N. M., Thakur, B. K., Vaidyanathan, S., Athalye, S. N.
10.1101/2021.10.25.21265462 — Posted: 2021-10-26
Outbreak of SARS-CoV-2 B.1.617.2 (Delta) variant in a Nursing Home 28 weeks after two doses of mRNA anti-Covid-19 vaccines: evidence of a waning immunity
Pierobon, A., Dal Zotto, A., Antico, A., De Antoni, M. E., Vianello, L., Gennari, M., Di Caprio, A., Russo, F., Brambilla, G., Saugo, M.
10.1101/2021.10.25.21265370 — Posted: 2021-10-26
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy
Hussey, H., Davies, M.-A., Heekes, A., Williamson, C., Valley-Omar, Z., Hardie, D. R., Korsman, S., Doolabh, D., Preiser, W., Maponga, T., Iranzadeh, A., Wasserman, S., Schrueder, N., Boloko, L., Raubenheimer, P., Symons, G., Parker, A., Viljoen, A., Cohen, C., JASSAT, W., Lessels, R., Wilkinson, R. J., Boulle, A., Hsiao, N.-y. M.
10.1101/2021.10.23.21265412 — Posted: 2021-10-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).